{
  "paper_metadata": {
    "pmid": "37347260",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted BRCA2 variant information, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.156_157insAlu",
      "protein_notation": "null",
      "genomic_position": "null",
      "clinical_significance": "Pathogenic",
      "patients": {
        "count": 5,
        "demographics": "Ages 33 to 67, male",
        "phenotype": "Male breast cancer, prostate cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 55,
        "affected_count": 4,
        "unaffected_count": 51,
        "uncertain_count": 0,
        "penetrance_percentage": 7.27,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "A",
          "age_at_evaluation": 63,
          "age_at_onset": null,
          "age_at_diagnosis": 60,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Luminal IDC in left breast with vascular invasion and focal nipple ulceration",
          "evidence_sentence": "Patient A: Luminal IDC in left breast with vascular invasion and focal nipple ulceration."
        },
        {
          "individual_id": "D",
          "age_at_evaluation": 46,
          "age_at_onset": null,
          "age_at_diagnosis": 44,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Prostate adenocarcinoma Gleason 8 (4+4) with perineural invasion and disseminated bone metastasis",
          "evidence_sentence": "Patient D: Prostate adenocarcinoma Gleason 8 (4+4) with perineural invasion and disseminated bone metastasis."
        },
        {
          "individual_id": "I",
          "age_at_evaluation": 67,
          "age_at_onset": null,
          "age_at_diagnosis": 65,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Prostate adenocarcinoma Gleason 9 (4+5) with biochemical relapse",
          "evidence_sentence": "Patient I: Prostate adenocarcinoma Gleason 9 (4+5) with biochemical relapse."
        },
        {
          "individual_id": "J",
          "age_at_evaluation": 72,
          "age_at_onset": null,
          "age_at_diagnosis": 77,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "In situ choroidal melanoma in right eye, glioblastoma IDH wild type",
          "evidence_sentence": "Patient J: In situ choroidal melanoma in right eye, glioblastoma IDH wild type."
        }
      ],
      "functional_data": {
        "summary": "The variant is classified as pathogenic based on clinical evidence.",
        "assays": []
      },
      "segregation_data": "The variant segregates with disease in families.",
      "population_frequency": "null",
      "evidence_level": "Strong evidence based on clinical data.",
      "source_location": "Table 2, Row 1",
      "additional_notes": "The variant is associated with male breast cancer and prostate cancer.",
      "key_quotes": [
        "Patient A: Luminal IDC in left breast with vascular invasion and focal nipple ulceration.",
        "Patient D: Prostate adenocarcinoma Gleason 8 (4+4) with perineural invasion and disseminated bone metastasis."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.608C>A",
      "protein_notation": "p.(Thr203Asn)",
      "genomic_position": "null",
      "clinical_significance": "VUS",
      "patients": {
        "count": 1,
        "demographics": "Age 62, male",
        "phenotype": "Invasive ductal carcinoma in left breast"
      },
      "penetrance_data": {
        "total_carriers_observed": 55,
        "affected_count": 0,
        "unaffected_count": 54,
        "uncertain_count": 1,
        "penetrance_percentage": 0.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "B",
          "age_at_evaluation": 62,
          "age_at_onset": null,
          "age_at_diagnosis": 59,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "IDC in left breast",
          "evidence_sentence": "Patient B: IDC in left breast."
        }
      ],
      "functional_data": {
        "summary": "The variant is classified as a variant of uncertain significance.",
        "assays": []
      },
      "segregation_data": "null",
      "population_frequency": "null",
      "evidence_level": "Limited evidence due to VUS classification.",
      "source_location": "Table 2, Row 2",
      "additional_notes": "The clinical significance of this variant remains uncertain.",
      "key_quotes": [
        "Patient B: IDC in left breast."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 2",
      "table_caption": "Symptomatic patients\u2019 characteristics [n=10]",
      "variants_extracted": 2
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant BRCA2 variants and penetrance data were extracted."
  }
}